Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2021
SKU ID : QYR-17094297 | Publishing Date : 05-Jan-2021 | No. of pages : 124
This report focuses on Radiopharmaceuticals in Nuclear Medical volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceuticals in Nuclear Medical market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Radiopharmaceuticals in Nuclear Medical Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Segment by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Medtronic
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region